Background: Abnormalities of gastrointestinal motility and transit time hav
e been reported in association with end-stage liver disease. Motility abnor
malities could be routinely studied if a simple noninvasive test were avail
able. The electrogastrogram is a cutaneous measure of gastric myoelectric a
ctivity and correlates well with serosal recordings of gastric myoelectric
activity. The aim of this study was to evaluate gastric myoelectric activit
y in patients with end-stage liver disease. Methods: Fourteen patients with
end-stage liver disease had gastric myoelectric activity measured with the
electrogastrogram. An electrogastrogram was considered abnormal when norma
l gastric dow waves were seen less than 70% of the time or there was no inc
rease in the electrogastrogram amplitude after a meal. Results: Abnormal el
ectrogastrograms were present in 8 of 14 (57%) end-stage liver disease pati
ents. Conclusions: Abnormal gastric myoelectric activity is common in end-s
tage liver disease.